文献速递糖尿病

金属螯合预防糖尿病心血管并发症的潜在作用

Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

综述探讨糖尿病致动脉粥样硬化与有毒金属暴露的关系,并汇总TACT等临床试验证据,提示铅、镉等金属可能是可干预的心血管风险因素,金属螯合在糖尿病患者中或有潜在获益。

要点

  • TACT试验显示依地酸二钠螯合改善既往心梗患者心血管结局,糖尿病亚组获益显著。
  • 铅、镉等广泛存在的有毒金属可能是糖尿病心血管疾病的可干预风险因素。
  • 金属螯合疗法的适应证尚未明确,需更多临床试验验证其安全性和疗效。

核心结论

  • TACT结果支持铅和镉等有毒金属可能是心血管疾病的可干预风险因素,尤其在糖尿病患者中。

研究设计与样本

  • 综述已发表文献,聚焦糖尿病致动脉粥样硬化性质及依地酸二钠金属螯合临床试验(已完成和进行中)。

主要发现

  • TACT是首个双盲随机对照试验,显示依地酸二钠改善既往心梗患者的心血管结局。
  • 在预先设定的糖尿病亚组中,依地酸二钠的治疗获益显著。

临床怎么用

  • 金属螯合疗法的适应证尚未明确,临床决策需基于更多循证证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: For decades, there has been epidemiologic evidence linking chronic toxic metal exposure with cardiovascular disease, suggesting a therapeutic role for metal chelation. Given the lack of compelling scientific evidence, however, the indications for metal chelation were never clearly defined. To determine the safety and efficacy of chelation therapy, the National Institutes of Health funded the Trial to Assess Chelation Therapy (TACT). TACT was the first double-blind, randomized, controlled trial to demonstrate an improvement in cardiovascular outcomes with edetate disodium therapy in patients with prior myocardial infarction. The therapeutic benefit was striking among the prespecified subgroup of patients with diabetes. DESIGN: We review the published literature focusing on the atherogenic nature of diabetes, as well as available evidence from clinical trials, complete and in progress, of metal chelation with edetate disodium therapy in patients with diabetes. RESULTS: The TACT results support the concept that ubiquitous toxic metals such as lead and cadmium may be modifiable risk factors for cardiovascular disease, particularly in patients with diabetes. CONCLUSIONS: The purpose of this review is to discuss the potential mechanisms unifying the pathogenesis of atherogenic factors in diabetes with toxic metal exposure, and the potential role of metal chelation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Calderon Moreno R, Navas-Acien A, Escolar E, et al. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes. J Clin Endocrinol Metab. 2019. PMID: 30869793. doi:10.1210/jc.2018-01484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。